PAHC Q4'26 Earnings: EPS estimate is 0.71 USD

PHIBRO ANIMAL HEALTH CORP (PAHC) filed an SEC Form 8-K — Results of Operations and Financial Condition.

Phibro Animal Health (NASDAQ:PAHC) shares rose 10.2% in the afternoon after director E. Thomas Corcoran bought $317,700 of stock on May 29: 10,000 shares at a weighted average $31.77. His holdings increased to 41,459 shares, according to the report. The stock is down 15.7% YTD at $31.43.

Scotiabank (BNS) reported Q3 earnings of Cdn$2.28 per share, beating estimates. Revenue rose 11% to Cdn$10.54B. Adjusted net income increased to Cdn$2.97B. Shares fell 0.81% post-announcement. Wealth and capital markets divisions set records, with earnings up 23% and 37% respectively. Return on equity reached 14.2%, exceeding the bank's target.

Everpure (NYSE: P) reported Q2 CY2026 revenue of $1.19B, up 37.7% YoY, exceeding expectations. Guidance for Q3 is $1.33B, 16.8% above estimates. Non-GAAP EPS of $0.70 beat consensus by 21%. The company highlights growth in Data Intelligence and AI products.

Agilent Technologies (NYSE: A) reported Q2 CY2026 revenue of $1.88B, up 8.1% YoY, exceeding estimates. Guidance for next quarter's revenue is $1.99B, 1% above analyst expectations. Non-GAAP EPS was $1.62, 9% above consensus. The company's 5-year revenue growth is 3.7% annualized, with 6.5% growth over the last two years. Adjusted operating margin is stable at 26.5%.

Nvidia's shares initially dipped but later jumped after its Q2 results, which beat estimates and raised Q3 guidance. Data center revenue surged 117% YoY to $89B, with Q3 revenue expected at $108B. CEO Jensen Huang forecast 70% revenue growth for fiscal 2028, citing AI's inflection point. Nvidia is a key player in AI, with major customers like Microsoft and Meta. Shares rose 4.2% post-results.